Ocular Therapeutix (OCUL) Reports Q4 Loss, Lags Revenue Estimates
28/2 23:35
Ocular Therapeutix (OCUL) came out with a quarterly loss of $0.23 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.23 per share a year ago. These figures are adjusted for non-recurring items....